Compare Stocks: DNA, TWST, BLFS, and PSNL

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BLFS BioLife Solutions	$36.69 -0.4%	$33.91	$17.86 ▼ $38.10	$1.79B	1.91	892,116 shs	1.03 million shs
DNA Ginkgo Bioworks	$7.88 +0.5%	$7.57	$5.37 ▼ $17.58	$530.64M	1.76	1.08 million shs	1.76 million shs
PSNL Personalis	$16.40 +1.0%	$15.04	$4.95 ▼ $18.89	$1.72B	2.31	3.03 million shs	3.18 million shs
TWST Twist Bioscience	$166.99 +7.3%	$118.99	$23.30 ▼ $167.05	$10.47B	2.22	1.57 million shs	3.07 million shs

7 Stocks That Will Be Magnificent in 2026

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BLFS BioLife Solutions	0.00%	+4.98%	-0.76%	+40.90%	+43.43%
DNA Ginkgo Bioworks	0.00%	+16.76%	+12.72%	-14.14%	-28.63%
PSNL Personalis	0.00%	+1.17%	-2.84%	+55.60%	+186.21%
TWST Twist Bioscience	0.00%	+31.26%	+22.49%	+90.71%	+519.17%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BLFS BioLife Solutions	$36.69 -0.4%	$33.91	$17.86 ▼ $38.10	$1.79B	1.91	892,116 shs	1.03 million shs
DNA Ginkgo Bioworks	$7.88 +0.5%	$7.57	$5.37 ▼ $17.58	$530.64M	1.76	1.08 million shs	1.76 million shs
PSNL Personalis	$16.40 +1.0%	$15.04	$4.95 ▼ $18.89	$1.72B	2.31	3.03 million shs	3.18 million shs
TWST Twist Bioscience	$166.99 +7.3%	$118.99	$23.30 ▼ $167.05	$10.47B	2.22	1.57 million shs	3.07 million shs

7 Stocks That Will Be Magnificent in 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BLFS BioLife Solutions	0.00%	+4.98%	-0.76%	+40.90%	+43.43%
DNA Ginkgo Bioworks	0.00%	+16.76%	+12.72%	-14.14%	-28.63%
PSNL Personalis	0.00%	+1.17%	-2.84%	+55.60%	+186.21%
TWST Twist Bioscience	0.00%	+31.26%	+22.49%	+90.71%	+519.17%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BLFS BioLife Solutions	2.18	Hold	$31.38	-14.49% Downside
DNA Ginkgo Bioworks	1.50	Reduce	$6.33	-19.62% Downside
PSNL Personalis	2.30	Hold	$14.54	-11.37% Downside
TWST Twist Bioscience	2.50	Moderate Buy	$103.00	-38.32% Downside

Current Analyst Ratings Breakdown

Latest DNA, TWST, BLFS, and PSNL Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/18/2026	TWST Twist Bioscience	BWS Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell	$45.00
9/17/2026	TWST Twist Bioscience	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Outperform	$120.00 ➝ $160.00
9/9/2026	DNA Ginkgo Bioworks	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$5.00
9/9/2026	TWST Twist Bioscience	BWS Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Sell	$45.00
9/9/2026	TWST Twist Bioscience	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Neutral	$144.00
9/7/2026	PSNL Personalis	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
9/4/2026	DNA Ginkgo Bioworks	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell	$5.00
8/24/2026	TWST Twist Bioscience	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
8/24/2026	PSNL Personalis	Craig Hallum Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy ➝ Hold	$16.25
8/17/2026	DNA Ginkgo Bioworks	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold
8/10/2026	BLFS BioLife Solutions	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy ➝ Hold

(Data available from 9/20/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BLFS BioLife Solutions	$96.21M	18.66	$0.23 per share	160.23	$7.72 per share	4.75
DNA Ginkgo Bioworks	$170.15M	3.12	N/A	N/A	$8.74 per share	0.90
PSNL Personalis	$69.65M	24.66	N/A	N/A	$2.94 per share	5.58
TWST Twist Bioscience	$376.57M	27.81	N/A	N/A	$7.84 per share	21.30

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BLFS BioLife Solutions	-$4.59M	$1.16	31.63	229.31	N/A	53.29%	2.70%	2.49%	11/5/2026 (Estimated)
DNA Ginkgo Bioworks	-$312.76M	-$5.01	N/A	N/A	N/A	-259.96%	-60.27%	-26.88%	11/5/2026 (Estimated)
PSNL Personalis	-$81.27M	-$1.09	N/A	N/A	N/A	-153.84%	-46.47%	-35.30%	11/3/2026 (Estimated)
TWST Twist Bioscience	-$77.67M	-$2.22	N/A	N/A	N/A	-31.66%	-28.64%	-19.94%	11/13/2026 (Estimated)

Latest DNA, TWST, BLFS, and PSNL Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/6/2026	Q2 2026	BLFS BioLife Solutions	$0.0313	$0.91	+$0.8788	$0.91	$27.80 million	$28.47 million
8/5/2026	Q2 2026	DNA Ginkgo Bioworks	-$0.8950	-$0.75	+$0.1450	-$0.75	$24.05 million	$20.16 million
8/4/2026	Q2 2026	PSNL Personalis	-$0.2633	-$0.30	-$0.0367	-$0.30	$16.69 million	$22.36 million
8/3/2026	Q3 2026	TWST Twist Bioscience	-$0.5063	-$0.56	-$0.0538	-$0.56	$114.55 million	$118.38 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BLFS BioLife Solutions	N/A	N/A	N/A	N/A	N/A
DNA Ginkgo Bioworks	N/A	N/A	N/A	N/A	N/A
PSNL Personalis	N/A	N/A	N/A	N/A	N/A
TWST Twist Bioscience	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BLFS BioLife Solutions	N/A	9.69	7.14
DNA Ginkgo Bioworks	N/A	4.57	4.57
PSNL Personalis	N/A	5.28	5.08
TWST Twist Bioscience	0.03	2.67	2.38

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BLFS BioLife Solutions	93.24%
DNA Ginkgo Bioworks	78.63%
PSNL Personalis	61.91%
TWST Twist Bioscience	N/A

Insider Ownership

Company	Insider Ownership
BLFS BioLife Solutions	2.20%
DNA Ginkgo Bioworks	12.69%
PSNL Personalis	4.20%
TWST Twist Bioscience	3.08%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BLFS BioLife Solutions	155	48.92 million	47.85 million	Optionable
DNA Ginkgo Bioworks	485	67.34 million	58.80 million	Optionable
PSNL Personalis	260	104.72 million	100.32 million	Optionable
TWST Twist Bioscience	979	62.71 million	60.78 million	Optionable

DNA, TWST, BLFS, and PSNL Headlines

Recent News About These Companies

BWS Financial Reiterates Sell Rating for Twist Bioscience (NASDAQ:TWST)

September 20 at 1:30 AM | americanbankingnews.com

922,647 Shares in Twist Bioscience Corporation $TWST Purchased by Bank of America Corp DE

September 19 at 3:06 AM | marketbeat.com

Why Twist Bioscience Stock Skyrocketed This Week

September 18 at 7:36 PM | fool.com

【TWST】Twist Bioscience W

September 18 at 2:01 PM | note.comN

Twist Bioscience (NASDAQ:TWST) Earns Sell Rating from BWS Financial

September 18 at 9:59 AM | marketbeat.com

TWST Stock Hits Multi-Year High, But ‘Pharma Bro’ Martin Shkreli Calls Twist A Short

September 17 at 7:31 PM | finance.yahoo.com

HAE, TWST Stocks Jump To Over 5-Year Highs – What’s Driving The Gains Today?

September 17 at 2:31 PM | finance.yahoo.com

Twist Bioscience (NASDAQ:TWST) Reaches New 52-Week High - Should You Buy?

September 17 at 10:59 AM | marketbeat.com

Twist Bioscience to Provide Antibody Data Services for Lilly TuneLab

September 16, 2026 | securities.ioS

Twist Bioscience Collaborating With Eli Lilly's TuneLab to Accelerate Antibody Drug Discovery

September 16, 2026 | finance.yahoo.com

Twist Bioscience Shares Rise On Lilly TuneLab Antibody Discovery Deal

September 16, 2026 | rttnews.com

Twist Bioscience (NASDAQ:TWST) Trading 5.8% Higher - Should You Buy?

September 16, 2026 | marketbeat.com

AI and Next-Gen Sequencing Strengthens Twist Bioscience Corp. (TWST)

September 16, 2026 | insidermonkey.com

Twist Bioscience Joins Lilly TuneLab to Advance Antibody Drug Discovery

September 16, 2026 | markets.ft.com

Engineers Gate Manager LP Takes $3.33 Million Position in Twist Bioscience Corporation $TWST

September 14, 2026 | marketbeat.com

California State Teachers Retirement System Purchases 5,181 Shares of Twist Bioscience Corporation $TWST

September 14, 2026 | marketbeat.com

Squarepoint Ops LLC Sells 113,545 Shares of Twist Bioscience Corporation $TWST

September 13, 2026 | marketbeat.com

VIRGINIA RETIREMENT SYSTEMS ET Al Buys New Stake in Twist Bioscience Corporation $TWST

September 12, 2026 | marketbeat.com

Twist Bioscience (NASDAQ:TWST) Insider Dennis Cho Sells 412 Shares

September 11, 2026 | insidertrades.com

Cours Twist Bioscience Corporation

September 11, 2026 | zonebourse.comZ

BWS Financial Initiates Coverage on Twist Bioscience (NASDAQ:TWST)

September 11, 2026 | americanbankingnews.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

DNA, TWST, BLFS, and PSNL Company Descriptions

BioLife Solutions NASDAQ:BLFS

$36.69 -0.16 (-0.43%)

Closing price 09/18/2026 04:00 PM Eastern

Extended Trading

$36.68 0.00 (-0.01%)

As of 09/18/2026 07:30 PM Eastern

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line that comprises of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides cryogenic freezer technology for controlled rate freezing and cryogenic storage of biologic materials; ultra-low temperature mechanical freezers; evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage and transport services. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.

Ginkgo Bioworks NYSE:DNA

$7.88 +0.04 (+0.50%)

Closing price 09/18/2026 03:59 PM Eastern

Extended Trading

$7.88 +0.00 (+0.03%)

As of 09/18/2026 07:57 PM Eastern

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Personalis NASDAQ:PSNL

$16.40 +0.17 (+1.05%)

Closing price 09/18/2026 04:00 PM Eastern

Extended Trading

$16.38 -0.02 (-0.15%)

As of 09/18/2026 07:30 PM Eastern

Personalis, Inc. develops and markets advanced cancer genomic tests and analytics primarily in the United States, Europe, and the Asia-Pacific. Its tests and analytics are used by pharmaceutical companies for translational research, biomarker discovery, and development of personalized cancer therapies, as well as advanced tests are used by physicians to detect cancer recurrence, monitor cancer evolution, and uncover insights for therapy selection. The company offers NeXT Personal, a tumor-informed liquid biopsy test for detection of minimal residual disease (MRD) and recurrence in cancer; and ImmunoID NeXT, a tissue-based test that combines whole exome (DNA) and whole transcriptome (RNA) sequencing data with advanced analytics to provide a multi-dimensional view of the tumor and the tumor microenvironment from a single sample. It also provides NeXT Personal Dx, a tumor-informed liquid biopsy test for detection of MRD and recurrence in cancer; and NeXT Dx, a comprehensive tumor profiling test that unlocks the entire exome (DNA) and transcriptome (RNA) with matched tumor-normal analysis. In addition, the company performs whole exome sequencing (WES) of cancer tissue and matched blood samples for diagnostic companies as an input to their products; and whole genome sequencing (WGS) on human samples for research projects, such as population sequencing initiatives, as well as offers sequencing and data analysis services to support population sequencing initiatives. Its customers include pharmaceutical companies, biopharmaceutical companies, diagnostics companies, universities, non-profits, government entities, and patients. The company was incorporated in 2011 and is headquartered in Fremont, California.

Twist Bioscience NASDAQ:TWST

$166.99 +11.43 (+7.35%)

Closing price 09/18/2026 04:00 PM Eastern

Extended Trading

$167.60 +0.61 (+0.37%)

As of 09/18/2026 07:53 PM Eastern

Twist Bioscience Corporation engages in the manufacture and sale of synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels, primarily used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, the company provides synthetic SARS-CoV-2 RNA reference sequences as positive controls for the development of both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries used for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company was incorporated in 2013 and is headquartered in South San Francisco, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest DNA, TWST, BLFS, and PSNL Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest DNA, TWST, BLFS, and PSNL Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

DNA, TWST, BLFS, and PSNL Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

DNA, TWST, BLFS, and PSNL Company Descriptions

BioLife Solutions NASDAQ:BLFS

Ginkgo Bioworks NYSE:DNA

Personalis NASDAQ:PSNL

Twist Bioscience NASDAQ:TWST

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest DNA, TWST, BLFS, and PSNL Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest DNA, TWST, BLFS, and PSNL Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

DNA, TWST, BLFS, and PSNL Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

DNA, TWST, BLFS, and PSNL Company Descriptions

BioLife Solutions NASDAQ:BLFS

Ginkgo Bioworks NYSE:DNA

Personalis NASDAQ:PSNL

Twist Bioscience NASDAQ:TWST

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools